Healthcare -
Biotechnology - NASDAQ - US
$ 9.235
-2.69 %
$ 2.84 B
Market Cap
-51.31
P/E
FOLD - CASH FROM OPERATIONS
Cash from Operations FOLD - Amicus Therapeutics, Inc.
-33.9 M
LAST VALUE
54.89%
2 YEAR CAGR
32.97%
5 YEAR CAGR
4.13%
10 YEAR CAGR